“…If these positives are properly channelled, they will motivate hospitals and patients in accepting generic medications. 11 Moreover, documented evidence showed that Physicians hold the key to enhancing the use Journal of Young Pharmacists, Vol 9, Issue 2, Apr-Jun, 2017 of generic medications. 21 Their attitudes reflect questionable differences in this generic versus branded saga and is due mainly to what they call observed variance in therapeutic outcomes.…”
Section: Discussionmentioning
confidence: 99%
“…9 According to US Food and Drug Administration (FDA), 10 generics are drug products that are comparable to branded/reference ones in dosage form, strength, route of administration, quality, performance characteristics and intended use. While it is true that Physicians and Pharmacists behaviour are key factors that can motivate patients to accept generic medications, 11 it is equally true that their non-acceptance of all-generic substitution promotes negative attitudes towards their use. The Saudi Government has mandated its Healthcare Institutions to embrace the idea of generic substitutions and hence its usage.…”
Objective: As population increase, Healthcare resources are stretched and the need to reduce prescription drug spending becomes obvious. The aim of this study was to evaluate the levels of generic prescribing in place of their branded counterparts among type 2 diabetic and hypertensive outpatients in Eastern region of Saudi Arabia. Method: A cross section of 13 Hospitals and 17 Community Pharmacies located in Al Ahsa, Dhahran, Khobar and Dammam (both Government and private) were visited. Out of which 58 Physicians and Pharmacists were interviewed with a structured questionnaire. Reasons for prescribing and serving either generic or branded were also ascertained. Patients' prescriptions were also examined at the various hospital and community pharmacies. Our focus was on prescription drugs for type 2 diabetic and hypertensive patients only and the study lasted for 6 months. Results: Findings revealed that only 26.9% generic medications were prescribed for both type 2 diabetic and hypertensive patients in the 13 hospitals sampled. It was also observed that while Government hospital prescribed 33.3% generics, private hospitals had 28.6% for same patient category. In the Community Pharmacies, only 23.5% generic were served for diabetics and 11.8% for hypertensive patients. Overall Hospitals branded prescription were 73.1% whereas in community Pharmacies, they represented 82.4% served medications. Conclusion: Levels of generic medication usage appeared to be significantly low. Majority of the Physicians and Pharmacists were of the belief that branded medications give better outcome to patients and this attitude could potentially render Government policies on the use of generic medication ineffective.
“…If these positives are properly channelled, they will motivate hospitals and patients in accepting generic medications. 11 Moreover, documented evidence showed that Physicians hold the key to enhancing the use Journal of Young Pharmacists, Vol 9, Issue 2, Apr-Jun, 2017 of generic medications. 21 Their attitudes reflect questionable differences in this generic versus branded saga and is due mainly to what they call observed variance in therapeutic outcomes.…”
Section: Discussionmentioning
confidence: 99%
“…9 According to US Food and Drug Administration (FDA), 10 generics are drug products that are comparable to branded/reference ones in dosage form, strength, route of administration, quality, performance characteristics and intended use. While it is true that Physicians and Pharmacists behaviour are key factors that can motivate patients to accept generic medications, 11 it is equally true that their non-acceptance of all-generic substitution promotes negative attitudes towards their use. The Saudi Government has mandated its Healthcare Institutions to embrace the idea of generic substitutions and hence its usage.…”
Objective: As population increase, Healthcare resources are stretched and the need to reduce prescription drug spending becomes obvious. The aim of this study was to evaluate the levels of generic prescribing in place of their branded counterparts among type 2 diabetic and hypertensive outpatients in Eastern region of Saudi Arabia. Method: A cross section of 13 Hospitals and 17 Community Pharmacies located in Al Ahsa, Dhahran, Khobar and Dammam (both Government and private) were visited. Out of which 58 Physicians and Pharmacists were interviewed with a structured questionnaire. Reasons for prescribing and serving either generic or branded were also ascertained. Patients' prescriptions were also examined at the various hospital and community pharmacies. Our focus was on prescription drugs for type 2 diabetic and hypertensive patients only and the study lasted for 6 months. Results: Findings revealed that only 26.9% generic medications were prescribed for both type 2 diabetic and hypertensive patients in the 13 hospitals sampled. It was also observed that while Government hospital prescribed 33.3% generics, private hospitals had 28.6% for same patient category. In the Community Pharmacies, only 23.5% generic were served for diabetics and 11.8% for hypertensive patients. Overall Hospitals branded prescription were 73.1% whereas in community Pharmacies, they represented 82.4% served medications. Conclusion: Levels of generic medication usage appeared to be significantly low. Majority of the Physicians and Pharmacists were of the belief that branded medications give better outcome to patients and this attitude could potentially render Government policies on the use of generic medication ineffective.
“…Com o aumento da oferta de medicamentos genéricos, pode ter havido maior variação na qualidade deles por causa da heterogeneidade do processo de produção, uma vez que a legislação permite um desvio da determinação quantitativa do fármaco em matérias-primas ou em formas farmacêuticas de 80 a 120% nos testes de biodisponibilidade 41 . Por outro lado, estudos têm demonstrado melhor aceitação dos genéri-cos por aqueles com experiência com esses medicamentos, mas aqueles que experimentaram mostraram boa percepção e aceitação dos medicamentos genéricos 7,42,43 .…”
Section: Discussionunclassified
“…As variáveis independentes estudadas foram sexo, idade (20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40)(41)(42)(43)(44)(45)(46)(47)(48)(49)(50)(51)(52)(53)(54)(55)(56)(57)(58)(59), 60 anos ou mais), escolaridade (0-4, 5-8 e 9 ou mais anos completos de estudo) e classe econômica baseada no Crité-rio de Classificação Econômica Brasileira vigente em cada ano (A são os mais ricos e E os mais pobres) 11,12 .…”
Resumo: Este estudo compara a percepção, conhecimento e uso de medicamentos genéricos em adultos de Pelotas, Rio Grande do Sul, Brasil, por meio de dois estudos transversais de base populacional realizados em 2002 e 2012. Os desfechos estudados foram: (a) prevalência de utilização de medicamentos genéricos; (b) proporção de uso de medicamentos genéricos entre os demais medicamentos; (c) percepção dos usuários sobre preço e qualidade dos medicamentos genéricos; (d) conhecimento dos usuários sobre medicamentos genéricos; e (e) estratégias de aquisição de medicamentos. A prevalência de uso de medicamentos genéricos aumentou de 3,6% (IC95%: 3,0-4,3) para 26,1% (IC95%: 24,5-27,7) no período de dez anos. A percepção sobre preço e qualidade dos medicamentos genéricos se manteve estável, a identificação das características que diferenciam os medicamentos genéricos dos demais medicamentos melhorou (p < 0,001) e o erro de classificação de medicamento diminuiu (p < 0,001). Houve um aumento significativo na estratégia de aquisição de medicamentos pela substituição do medicamento prescrito pelo medicamento genérico. Entre 2002 e 2012, aumentou o conhecimento e uso de medicamentos genéricos, enquanto a percepção quanto ao menor preço e qualidade equivalente mantiveram-se elevadas.
“…Quite unexpectedly another finding was reported -clear contrast between rather supportive attitude of pharmacists towards generics use and their behavior in everyday practice heavily neglecting recommendation of generics to the patients. Besides aforementioned reasons, lack of stocked generics in pharmacies and modest market availability of generic replacement for only 43.7 % of brand name medicines were listed among contributing factors [50].…”
Section: Attitudes On Generic Medicines Prescription and Dispensingmentioning
2
SummaryJapanese pharmaceutical market, world's 2 nd largest in size, is traditionally renowned for its brands' domination and weakest generics share among major established economies. An in depth observation of published evidence in Japanese/English language provided closer insight into current trends in Japanese domestic legislation and pharmaceutical market development. Recent governmental interventions have resulted in significant expansion of generic medicines market size. Substantial savings due to generic substitution of brand name drugs have already been achieved and are likely to increase in future. Nationwide population aging threatening sustainable health care funding is contributing to the relevance of generic policy success. Serious long-term challenge to the modest Japanese generic manufacturing capacities will be posed by foreign pharmaceutical industries particularly the ones based in emerging BRIC economies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.